| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Malte Bertram, Claire V Warren, Florian Lange, Caroline Seer, Alexander Steinke, Florian Wegner, Christoph Schrader, Dirk Dressler, Reinhard Dengler, Bruno Kop. Dopaminergic modulation of novelty repetition in Parkinson's disease: A study of P3 event-related brain potentials. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. vol 131. issue 12. 2021-05-25. PMID:33137574. |
parkinson's disease (pd) is a neurodegenerative disease caused by the loss of dopaminergic neurons. |
2021-05-25 |
2023-08-13 |
Not clear |
| Kevin M Budge, Matthew L Neal, Jason R Richardson, Fayez F Safad. Transgenic Overexpression of GPNMB Protects Against MPTP-Induced Neurodegeneration. Molecular neurobiology. vol 57. issue 7. 2021-05-19. PMID:32436108. |
parkinson's disease (pd) is a progressive neurodegenerative disease highlighted by a marked loss of dopaminergic cell loss and motor disturbances. |
2021-05-19 |
2023-08-13 |
mouse |
| Patricia García-Sanz, Johannes M F G Aerts, Rosario Moratall. The Role of Cholesterol in α-Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society. vol 36. issue 5. 2021-05-19. PMID:33219714. |
parkinson's disease (pd) is a progressive neurodegenerative disease where dopaminergic neurons in the substantia nigra are lost, resulting in a decrease in striatal dopamine and, consequently, motor control. |
2021-05-19 |
2023-08-13 |
Not clear |
| Cheng-Fu Su, Li Jiang, Xiao-Wen Zhang, Ashok Iyaswamy, Min L. Resveratrol in Rodent Models of Parkinson's Disease: A Systematic Review of Experimental Studies. Frontiers in pharmacology. vol 12. 2021-05-13. PMID:33967780. |
parkinson's disease (pd) is a common neurodegenerative disease featured by progressive degeneration of nigrostriatal dopaminergic neurons (da) accompanied with motor function impairment. |
2021-05-13 |
2023-08-13 |
Not clear |
| Luca Magistrelli, Marco Ferrari, Alessia Furgiuele, Anna Vera Milner, Elena Contaldi, Cristoforo Comi, Marco Cosentino, Franca Marin. Polymorphisms of Dopamine Receptor Genes and Parkinson's Disease: Clinical Relevance and Future Perspectives. International journal of molecular sciences. vol 22. issue 7. 2021-05-12. PMID:33917417. |
parkinson's disease (pd) is a neurodegenerative disease caused by loss of dopaminergic neurons in the midbrain. |
2021-05-12 |
2023-08-13 |
Not clear |
| Min Kyung Song, Joo Hee Lee, Jinil Kim, Ji Hyun Kim, Soonhye Hwang, Yoon-Seong Kim, Youn-Jung Ki. Neuroprotective effect of NXP031 in the MPTP-induced Parkinson's disease model. Neuroscience letters. vol 740. 2021-05-07. PMID:33075422. |
parkinson's disease (pd) is a neurodegenerative disease characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra (sn). |
2021-05-07 |
2023-08-13 |
mouse |
| Junqiang Yan, Jiarui Huang, Anran Liu, Jiannan Wu, Hua Fan, Mengmeng Shen, Xiaoyi Lai, Hongxia Ma, Wenjie Sun, Jianxue Yang, Yunqi X. Atorvastatin improves motor function, anxiety and depression by NOX2-mediated autophagy and oxidative stress in MPTP-lesioned mice. Aging. vol 13. issue 1. 2021-05-07. PMID:33289703. |
parkinson's disease (pd) is a neurodegenerative disease caused by the loss of dopaminergic neurons. |
2021-05-07 |
2023-08-13 |
mouse |
| Zihua Liu, Qiang Ye, Fang Wang, Yanan Guo, Rong Cui, Jianlin Wang, Degui Wan. Protective effect of thioredoxin reductase 1 in Parkinson's disease. Neuroscience letters. vol 741. 2021-05-04. PMID:33171211. |
parkinson's disease (pd) is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra (sn). |
2021-05-04 |
2023-08-13 |
mouse |
| Sunita Chawla, Dnyaneshwar Kalyane, Vishakha Tambe, Pran Kishore Deb, Kiran Kalia, Rakesh K Tekad. Evolving nanoformulation strategies for diagnosis and clinical interventions for Parkinson's disease. Drug discovery today. vol 25. issue 2. 2021-04-30. PMID:31877354. |
parkinson's disease (pd) is the most common neurodegenerative disease and is associated with a loss of dopaminergic neurons in the substantia nigra. |
2021-04-30 |
2023-08-13 |
Not clear |
| Yang Xie, Shujiang Zhang, Zhiyu Lv, Ting Long, Ying Luo, Zuoxiao L. SOX21-AS1 modulates neuronal injury of MMP Neuroscience letters. vol 746. 2021-04-29. PMID:33421490. |
sox21-as1 modulates neuronal injury of mmp parkinson's disease (pd), caused by the decreased number of dopaminergic neurons in the substantia nigra, is identified as the second most familiar age-dependent neurodegenerative disease to the public. |
2021-04-29 |
2023-08-13 |
Not clear |
| Alexandra Petie. Current and Emerging MR Methods and Outcome in Rodent Models of Parkinson's Disease: A Review. Frontiers in neuroscience. vol 15. 2021-04-28. PMID:33897339. |
parkinson's disease (pd) is a major neurodegenerative disease characterized by massive degeneration of the dopaminergic neurons in the substantia nigra pars compacta, α-synuclein-containing lewy bodies, and neuroinflammation. |
2021-04-28 |
2023-08-13 |
Not clear |
| Neha Milind Chitre, Bo Jarrett Wood, Azizi Ray, Nader H Moniri, Kevin Sean Murnan. Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum. Neuropharmacology. vol 167. 2021-04-23. PMID:32001239. |
parkinson's disease (pd) is a devastating neurodegenerative disease that leads to motor deficits and selective destruction of nigrostriatal dopaminergic neurons. |
2021-04-23 |
2023-08-13 |
rat |
| Mykel A Robble, Mary E Bozsik, Daniel S Wheeler, Robert A Wheele. Learned avoidance requires VTA KOR-mediated reductions in dopamine. Neuropharmacology. vol 167. 2021-04-23. PMID:32057802. |
proper learning from an aversive experience is essential for survival, yet it is an aberrant process in a wide range of mental disorders, as well as dopaminergic neurodegenerative disease. |
2021-04-23 |
2023-08-13 |
rat |
| Nergis Selma Aslan, Gürdal Orhan, Bensu Karahali. The impacts of prominent gene polymorphisms in DNA repair enzymes on Parkinson's disease. Neuroscience letters. vol 735. 2021-04-23. PMID:32603833. |
parkinson's disease (pd), a chronic and progressive neurodegenerative disease of the brain, is associated with the loss of dopaminergic neurons. |
2021-04-23 |
2023-08-13 |
human |
| Eliana Jardim Fernandes, Marcia Rósula Poetini, Magna Sotelo Barrientos, Vandreza Cardoso Bortolotto, Stífani Machado Araujo, Elize Aparecida Santos Musachio, Amarilis Santos De Carvalho, Fernanda Vitória Leimann, Odinei Hess Gonçalves, Bruna Piaia Ramborger, Rafael Roehrs, Marina Prigol, Gustavo Petri Guerr. Exposure to lutein-loaded nanoparticles attenuates Parkinson's model-induced damage in Drosophila melanogaster: Restoration of dopaminergic and cholinergic system and oxidative stress indicators. Chemico-biological interactions. vol 340. 2021-04-22. PMID:33716020. |
parkinson's is a neurodegenerative disease, characterized by the loss of dopaminergic neurons, cholinergic alterations and oxidative damages. |
2021-04-22 |
2023-08-13 |
drosophila_melanogaster |
| C Costas, L R F Far. Do naturally occurring antioxidants protect against neurodegeneration of the dopaminergic system? A systematic revision in animal models of Parkinson's disease. Current neuropharmacology. 2021-04-22. PMID:33882808. |
parkinson's disease (pd) is the second most common neurodegenerative disease and is characterized by a significant decrease in dopamine levels, caused by progressive degeneration of the dopaminergic neurons in the nigrostriatal pathway. |
2021-04-22 |
2023-08-13 |
Not clear |
| Joana Silva, Celso Alves, Alice Martins, Patrícia Susano, Marco Simões, Miguel Guedes, Stephanie Rehfeldt, Susete Pinteus, Helena Gaspar, Américo Rodrigues, Márcia Ines Goettert, Amparo Alfonso, Rui Pedros. Loliolide, a New Therapeutic Option for Neurological Diseases? In Vitro Neuroprotective and Anti-Inflammatory Activities of a Monoterpenoid Lactone Isolated from International journal of molecular sciences. vol 22. issue 4. 2021-04-19. PMID:33672866. |
in vitro neuroprotective and anti-inflammatory activities of a monoterpenoid lactone isolated from parkinsons disease (pd) is the second most common neurodegenerative disease worldwide, and is characterized by a progressive degeneration of dopaminergic neurons. |
2021-04-19 |
2023-08-13 |
Not clear |
| Mahesh Ramalingam, Sujeong Jang, Han-Seong Jeon. Neural-Induced Human Adipose Tissue-Derived Stem Cells Conditioned Medium Ameliorates Rotenone-Induced Toxicity in SH-SY5Y Cells. International journal of molecular sciences. vol 22. issue 5. 2021-04-16. PMID:33652595. |
parkinson's disease (pd) is an age-related neurodegenerative disease (ndd) characterized by the degenerative loss of dopaminergic neurons in the substantia nigra along with aggregation of α-synuclein (α-syn). |
2021-04-16 |
2023-08-13 |
human |
| Yumin Zheng, Li Dong, Na Liu, Xiaoguang Luo, Zhiyi H. Mir-141-3p Regulates Apoptosis and Mitochondrial Membrane Potential via Targeting Sirtuin1 in a 1-Methyl-4-Phenylpyridinium in vitro Model of Parkinson's Disease. BioMed research international. vol 2020. 2021-04-15. PMID:33204711. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by the loss of midbrain dopaminergic neurons in the substantia nigra. |
2021-04-15 |
2023-08-13 |
Not clear |
| Sodam Won, Jade Heejae Ko, Hayoung Jeon, Seong-Sik Park, Seung-Nam Ki. Co-Administration of Gagam-Sipjeondaebo-Tang and Ibuprofen Alleviates the Inflammatory Response in MPTP-Induced Parkinson's Disease Mouse Model and RAW264.7 Macrophages. Pathogens (Basel, Switzerland). vol 10. issue 3. 2021-04-13. PMID:33652920. |
parkinson's disease (pd), a common neurodegenerative disease, is characterized by degeneration of dopaminergic neurons with neuroinflammation. |
2021-04-13 |
2023-08-13 |
mouse |